Joseph D Margolis, the Chief Executive Officer of $EXR, sold 7,500 shares of the company on 10-01-2025 for an estimated $1,060,575. We received data on the trade from a recent SEC filing. This was a sale of approximately 27.5% of their shares of this class of stock. Following this trade, they now own 19,760 shares of this class of $EXR stock.
$EXR Insider Trading Activity
$EXR insiders have traded $EXR stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $EXR stock by insiders over the last 6 months:
- JOSEPH D MARGOLIS (Chief Executive Officer) has made 0 purchases and 2 sales selling 15,000 shares for an estimated $2,188,200.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EXR Hedge Fund Activity
We have seen 386 institutional investors add shares of $EXR stock to their portfolio, and 361 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,049,241 shares (-90.4%) from their portfolio in Q2 2025, for an estimated $302,140,093
- BLACKROCK, INC. removed 1,081,923 shares (-4.8%) from their portfolio in Q2 2025, for an estimated $159,518,727
- RESOLUTION CAPITAL LTD added 1,048,685 shares (+116.2%) to their portfolio in Q2 2025, for an estimated $154,618,116
- COHEN & STEERS, INC. removed 1,011,943 shares (-6.7%) from their portfolio in Q2 2025, for an estimated $149,200,875
- NORGES BANK added 903,478 shares (+14.4%) to their portfolio in Q2 2025, for an estimated $133,208,796
- GOLDMAN SACHS GROUP INC added 694,018 shares (+37.2%) to their portfolio in Q2 2025, for an estimated $102,326,013
- CITADEL ADVISORS LLC added 683,605 shares (+321.9%) to their portfolio in Q2 2025, for an estimated $100,790,721
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EXR Analyst Ratings
Wall Street analysts have issued reports on $EXR in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 09/16/2025
- Scotiabank issued a "Sector Outperform" rating on 08/28/2025
- Wells Fargo issued a "Overweight" rating on 08/26/2025
- Barclays issued a "Overweight" rating on 08/08/2025
- Mizuho issued a "Outperform" rating on 05/28/2025
- Benchmark issued a "Buy" rating on 05/13/2025
To track analyst ratings and price targets for $EXR, check out Quiver Quantitative's $EXR forecast page.
$EXR Price Targets
Multiple analysts have issued price targets for $EXR recently. We have seen 13 analysts offer price targets for $EXR in the last 6 months, with a median target of $153.0.
Here are some recent targets:
- Steve Sakwa from Evercore ISI Group set a target price of $149.0 on 10/03/2025
- Michael Goldsmith from UBS set a target price of $160.0 on 09/16/2025
- Nicholas Yulico from Scotiabank set a target price of $162.0 on 08/28/2025
- Eric Luebchow from Wells Fargo set a target price of $160.0 on 08/26/2025
- Smedes Rose from Citigroup set a target price of $150.0 on 08/22/2025
- Caitlin Burrows from Goldman Sachs set a target price of $146.0 on 08/21/2025
- Ki Bin Kim from Truist Securities set a target price of $150.0 on 08/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
